While the preclinical data for fasting in cancer are compelling, its practical application requires careful consideration of clinical feasibility and patient adherence. Fasting protocols must be safe, especially for patients who may already be frail or experiencing cancer cachexia. Research focuses on designing practical and tolerable intermittent fasting schedules or nutrient-defined... https://www.beatcancerfoundation.org/